From developing new energy storage materials to revealing patterns of Earth’s complex systems, studies led by PNNL researchers are recognized for their innovation and influence.
Ampcera has an exclusive licensing agreement with PNNL to commercially develop and license a new battery material for applications such as vehicles and personal electronics.
PNNL biodefense experts seek to identify, understand and mitigate the risks of biological pathogens—whether naturally occurring or intentionally created—so steps can be taken to prepare and respond.
Research at PNNL and the University of Texas at El Paso are addressing computational challenges of thinking beyond the list and developing bioagent-agnostic signatures to assess threats.
Spatial proteomics enables researchers to link protein measurements to features in the image of a tissue sample, which are lost using standard approaches.
Clean hydrogen energy infrastructure is coming to the Pacific Northwest with a newly announced hydrogen hub, and PNNL experts are advising the work to come.
At the Nonproliferation, Counterproliferation, and Disarmament Science Gordon Research Conference, researchers from PNNL shared research and scientific approaches for countering diverse threats.
Steven Spurgeon’s research is featured in the cover of the MRS Bulletin along with his team’s invited perspective on the future of machine learning for electron and scanning probe microscopy.
New research findings published in Science Advances (November 2022), help explain the progression of Alzheimer-related dementia in each patient. The findings outline a biological classification system that predicts disease severity.
Johannes Lercher, Battelle Fellow and director of the PNNL Institute for Integrated Catalysis, envisions energy storage solutions at the new Energy Sciences Center.
